Impact News +++ Enovix Q3 GAAP EPS of $0.19, revenue of $11M (SeekingAlpha) +++ ENOVIX Aktie -3,30%

INTEGRA LIFESCIENCES Aktie

>INTEGRA LIFE Aktienkurs

11.85 EUR (TradegateBSX)

Ask: 11.9 EUR / 600 Stück

Bid: 11.8 EUR / 600 Stück

Tagesumsatz: 0 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

INTEGRA LIFE Aktie über LYNX handeln

Intraday

1 Jahr

>INTEGRA LIFE Performance

1 Woche: +6,0%

1 Monat: -7,1%

3 Monate: -23,9%

6 Monate: +42,5%

1 Jahr: +6,9%

laufendes Jahr: +14,8%

>INTEGRA LIFESCIENCES Aktie

Profil:

Integra LifeSciences Holdings Corporation is a medical technology company that develops, manufactures, and markets products used in neurosurgery, regenerative medicine, and surgical reconstruction. The company’s current business is organized around..
>Volltext..

Insiderhandel:

>INTEGRA LIFE Kennzahlen

Aktien/ Unternehmen:

Analysten:

Bewertung:

Rentabilität:

Managementeffizenz:

>INTEGRA LIFE Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>INTEGRA LIFE Chart & Kurs - NASDAQ

>INTEGRA LIFE News

09.10.26 - 23:42	Integra LifeSciences prices $450M in 9.5% secured notes (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

09.10.26 - 23:24

Integra Announces Pricing of Senior Secured Notes (GlobeNewswire EN)

Integra LifeSciences Holdings Corporation (NASDAQ:IART) (the “Company”) today announced the pricing of $450,000,000 aggregate principal amount of 9.500% senior secured notes due 2033 (the “Notes”). The Notes will be general senior secured obligations of the Company and will be guaranteed by the Company's wholly-owned domestic subsidiaries that are guarantors under the Company's senior secured credit facilities. The sale of the Notes is expected to close on or about October 19, 2026, subject to customary closing conditions....

06.10.26 - 14:33	Integra LifeSciences to Host Third Quarter 2026 Financial Results Conference Call on October 21, 2026 (GlobeNewswire EN)
	PRINCETON, N.J., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release third quarter 2026 financial results on Wednesday, October 21, 2026, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET....

03.10.26 - 00:45	Integra LifeSciences Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Integra LifeSciences (IART) (PR Newswire)
	A $4.3 million to $6.3 million gap between Integra's preliminary third-quarter revenue and the Wall Street estimate sent IART shares lower. SueWallSt notifies investors of a pending investigation into potential securities claims for shareholders who lost money. NEW YORK, Oct. 2, 2026......

02.10.26 - 22:36	Integra LifeSciences plunges 21% on preliminary Q3 results (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

02.10.26 - 18:00	Integra LifeSciences lowers revenue and earnings outlook for 2026 (Proactive Investors)
	Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...

02.10.26 - 16:54	Integra LifeSciences-Aktie stürzt nach Prognosesenkung und Produktionsausfällen ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.10.26 - 16:18	Integra LifeSciences-Aktie stürzt nach Prognosesenkung für 2026 ab (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.10.26 - 16:01	Integra LifeSciences stock tumbles after cutting 2026 outlook (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

02.10.26 - 14:06	Integra LifeSciences Announces Preliminary Third Quarter Results and Updates Full-Year 2026 Guidance (GlobeNewswire EN)
	PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today provided certain unaudited preliminary third quarter results and an update to its full-year 2026 guidance....

02.10.26 - 14:03	Integra LifeSciences Announces Launch of $600 Million Senior Secured Term Loan B (GlobeNewswire EN)
	PRINCETON, N.J., Oct. 02, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced the launch of a proposed $600 million seven-year Senior Secured Term Loan B as part of a broader refinancing transaction....

29.09.26 - 14:31	Integra LifeSciences Announces 100th Patient Enrolled in AERA® Pediatric Registry (GlobeNewswire EN)
	Prospective, multicenter registry advances toward planned enrollment of 300 pediatric patients Prospective, multicenter registry advances toward planned enrollment of 300 pediatric patients...

25.09.26 - 15:06	Integra LifeSciences Marks 20 Years of CUSA® Technology with Liver Surgery Education at ACS Clinical Congress 2026 (GlobeNewswire EN)
	Company to feature surgeon-led educational programming and technologies supporting liver surgery Company to feature surgeon-led educational programming and technologies supporting liver surgery...

09.09.26 - 21:30	Integra LifeSciences auf der Wells Fargo Healthcare-Konferenz: Erholung gewinnt an Fahrt (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

30.07.26 - 11:30	Zacks.com featured highlights include Bassett Furniture, Aveanna Healthcare and Integra LifeSciences (Zacks)
	Bassett Furniture, Aveanna Healthcare and Integra LifeSciences are highlighted as potential breakout stocks using support and resistance levels ahead of August....

29.07.26 - 15:15	Integra LifeSciences (IART) Q2 Earnings Top Estimates (Zacks)
	Integra (IART) delivered earnings and revenue surprises of +16.67% and -0.20%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?...

29.07.26 - 12:21	Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.56 beats by $0.08, revenue of $418.7M beats by $1.16M (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

29.07.26 - 12:03	Integra LifeSciences Reports Second Quarter 2026 Financial Results (GlobeNewswire EN)
	PRINCETON, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2026....

28.07.26 - 18:48	Integra LifeSciences Holdings Corporation Q2 2026 Earnings Preview (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

15.07.26 - 19:45	IART Stock Surges 52.1% in a Year: What′s Driving the Rally? (Zacks)
	Integra LifeSciences has climbed 52.1% in a year as growth across both segments, improved execution and transformation efforts continue to boost results....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Man sollte niemals vergessen: auch Damen gehören zu den Weibern. - Peter Bamm

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram